Tofajak 5 Tablet is used to manage moderate to severe rheumatoid arthritis, active psoriatic arthritis and moderate to severe ulcerative colitis in adults under specialist supervision, when other treatments have not worked well enough.
It contains tofacitinib (5 mg), a JAK inhibitor. Take it as prescribed; do not stop without medical advice.
Keeping to all monitoring appointments for blood counts, liver function and lipid levels, and being up to date with vaccinations before starting, supports safe treatment alongside this medicine.
Tell your doctor about any history of serious infection, tuberculosis, blood clots, cancer, cardiovascular disease or kidney problems before starting. Tofacitinib can increase the risk of serious infections, blood clots (VTE) and certain cancers. Do not start if you have an active infection. Report signs of infection, breathlessness, leg pain and swelling, or any new lumps immediately.

















































































